Report Categories
View AllRecent Articles
View All
Aprea APRE Delivers Q1 2026 Beat EPS 022 vs 023 Expected
UMB UMBFO Q1 2026 Earnings EPS 335 Beats Estimates
K2 Capital KTWOU Stock Analysis RangeBound Near 1007 20260515
Global GSL Stock Analysis Flat at 4115 Whats Next 20260514
EHAB Q4 2025 Earnings Slight EPS Miss Amid Steady Operational Execution
Zydus Lifesciences Surges to Record High After Strong Quarterly Earnings and Share Buyback Announcement
Tesla TSLA Slides Amid Rising Capital Expenditure Concerns
Sight Sciences SGHT Q1 2026 Results Disappoint Multiple Headwinds Cited
Burberry Shares Surge on Report of Potential Moncler Takeover Bid
UK Dirty Money Flows Estimated at 325bn Annually Sparking Regulatory Concerns
Bearish Signals Emerge for Canadian Dollar as Rate Hike Expectations Weigh
Jobless Claims Remain Subdued Signaling Continued Labor Market Tightness
NFL Seeks Ban on Certain Prediction Market Contracts Including Player Injuries and First Play Outcomes
Gold and Silver Decline as Precious Metals Face Selling Pressure
EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge
BBUC Q1 2026 Earnings Profitability Shines in a Quiet Quarter
CMG Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines 176
First Community Bankshares Inc FCBC Q1 2026 Earnings Slight EPS Miss as Bank Posts Steady Operating Results
VEON Q1 2026 Earnings EPS Beats Estimates Amid Operational Progress
Standard Motor Products SMP Surges 5 Breaking Above Key Support Zone
AXIL Brands Finds Floor at Support Eyes Resistance Amid Low Volume
Nuwellis Inc NUWE Rallies 537 as Stock Tests Key Resistance Levels
Universal Corporation UVV Edges Higher as Price Nears Key Support
MLAB Q1 2026 Earnings Earnings Per Share Surges Past Estimates by Over 130
AL Q4 2025 Earnings EPS Surges Past Estimates by 239
SBH Q1 2026 Earnings EPS Beats Estimates Amid Corporate Transition
Endeavour Silver EXK Q1 2026 Earnings Silver Producer Beats EPS Estimates by Nearly 60 Shares Dip Slightly
Monarch Casino Resort Inc MCRI Q1 2026 Earnings EPS Surges 349 Above Expectations
Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses